METABOLIC EFFECTS OF THYROID HORMONE
METABOLIC EFFECTS OF THYROID HORMONE
批准号:
3483146
负责人:
HERBERT H SAMUELS
金额:
$47.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-03-01 至 1996-03-31
关键词:
DNA binding protein Escherichia coli affinity chromatography affinity labeling cell growth regulation circular dichroism conformation fibroblasts gel mobility shift assay gene expression genetic manipulation genetic regulatory element genetic transcription growth factor receptors hormone metabolism hormone receptor hormone regulation /control mechanism human genetic material tag human tissue ligands molecular cloning nuclear magnetic resonance spectroscopy protein purification retinoate site directed mutagenesis somatotropin thyroid hormones tissue /cell culture transcription factor transfection
中文摘要
甲状腺激素受体(c-Erbas)和维甲酸受体(RARs)
是亲缘关系密切的核受体蛋白亚群的成员。
C-Erbas和RAR各自可以激活某些反应元件,并且两者
受体含有一个嵌入在配体内的高度保守的结构域
结合区含有一系列“亮氨酸拉链样”疏水物质
七元图案。功能研究表明,七肽重复结构域
介导c-erba和RAR的同源和异源二聚体相互作用
与其他因素的相互作用。鸡c-erba-α和人RAR-α
已经在大肠杆菌中表达,并纯化到接近均一的水平。这些
受体以适当的亲和力结合配体,形成同源异构体
允许二聚化的响应元件上的杂二聚体。
配体促进了二聚体的形成,提示配体介导
通过这种机制进行转录激活。此应用程序是一个
全面的建议书,以定义
转录激活中的c-erba、RAR及相关因子。为
这些研究我们构建了多功能细菌/真核生物
表达载体(PEXPRESS),允许定点突变和
可用于对真核细胞中的受体进行功能分析和
在大肠杆菌中高效表达受体。凝胶漂移研究使用
纯化的野生型和突变型受体蛋白以及多种天然的
并提出了合成反应要素来解释规则。
它控制着这些受体如何识别功能反应元件。
这些研究还将定义对Homo-And至关重要的受体结构域
异源二聚体的形成,用于受体之间的协同作用
和其他因素,以及占主导地位的消极活动。可能的
C-erba亚型(字母和贝塔尔)对元素识别的差异
也将与了解差异的研究一起进行检查
V-erba和c-erba之间的关系以及c-erba-alpha2如何发挥支配作用
负调节器。这些研究将通过分析
来自甲状腺激素患者的受体突变
耐药综合征。哺乳动物细胞的功能研究将是
扩展到体外转录,目的是定义蛋白质
以及这些受体转录增强所需的DNA。
最后,对纯化后的大肠杆菌中镁的利用率进行了研究
野生型c-erba及其DNA结合域将允许循环
二向色性、荧光和紫外可见光谱(两者
蛋白质)和核磁共振研究(DNA结合结构域)以
提供结构信息以阐明功能和物理
这些蛋白质在分子水平上的性质。
英文摘要
Thyroid hormone receptors (c-erbAs) and retinoic acid receptors (RARs)
are members of a subgroup of closely related nuclear receptor proteins.
c-erbAs and RAR can each activate certain response elements and both
receptors contain a highly conserved domain embedded within the ligand
binding region containing a series of "leucine-zipper-like" hydrophobic
heptad motifs. Functional studies suggest that the heptad repeat domain
mediates homo- and heterodimeric interactions of c-erbA and RAR or
interactions with other factors. Chick c-erbA-alpha and human RAR-alpha
have been expressed in E. coli and purified to near homogeneity. These
receptors bind ligand with appropriate affinity and form homo- and
hetero-dimers on response elements which are permissive for dimerization.
Dimer formation is enhanced by ligand suggesting that ligand mediates
transcriptional activation by this mechanism. This application is a
comprehensive proposal to define the functional domains involved in
c-erbA, RAR, and related factors in transcriptional activation. For
these studies we constructed a multifunctional bacterial/eucaryotic
expression vector (pEXPRESS) which permits site directed mutagenesis and
can be used to functionally analyze receptor in eucaryotic cells and to
express receptor at high levels in E. coli. Gel shift studies using
purified wild-type and mutant receptor proteins and a variety of native
and synthetic response elements are proposed to elucidate the "rules"
which govern how these receptors recognize functional response elements.
These studies will also define receptor domains critical for homo- and
hetero-dimer formation, for cooperative interactions between receptors
and other factors, and for dominant negative activities. Possible
differences in element recognition by c-erbA subtypes (alphal and betal)
will also be examined along with studies to understand differences
between v-erbA and c-erbA and how c-erbA-alpha2 functions as a dominant
negative regulator. These studies will be complemented by analyzing
receptor mutants derived from patients with the thyroid hormone
resistance syndrome. Functional studies in mammalian cells will be
extended to in vitro transcription with the goal of defining the protein
and DNA requirements for transcriptional enhancement by these receptors.
Finally, the availability of mg amounts of purified E. coli expressed
wild-type c-erbA and its DNA binding domain will allow circular
dichroism, fluorescence, and ultraviolet-visible spectroscopy (both
proteins), and nuclear magnetic resonance studies (DNA binding domain) to
provide structural information to elucidate the functional and physical
properties of these proteins at the molecular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AMERSHAM BIOSCIENCES TYPHOON 9410; NEUROSCIENCES
-
批准号:7335290
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
AMERSHAM BIOSCIENCES TYPHOON 9410: PHARMACOLOGY, CELL BIOLOGY, MICROBIOLOGY
-
批准号:7335287
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
AMERSHAM BIOSCIENCES TYPHOON 9410: DRUG ABUSE
-
批准号:7335289
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
AMERSHAM BIOSCIENCES TYPHOON 9410: DIABETES
-
批准号:7335288
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
Amersham Biosciences Typhoon 9410
-
批准号:7047286
-
项目类别:
-
资助金额:$14.82万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7088804
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:6914861
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7695223
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:8094304
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7454116
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7250038
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:6697544
-
项目类别:
-
资助金额:$8.83万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7876978
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
GLUCOCORTICOID RECEPTORS--STRUCTURE AND FUNCTION
-
批准号:3241709
-
项目类别:
-
资助金额:$20.98万
-
财政年份:1989
-
负责人:HERBERT H SAMUELS
-
依托单位:
GLUCOCORTICOID RECEPTORS--STRUCTURE AND FUNCTION
-
批准号:3241708
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1989
-
负责人:HERBERT H SAMUELS
-
依托单位:
GLUCOCORTICOID RECEPTORS--STRUCTURE AND FUNCTION
-
批准号:3241707
-
项目类别:
-
资助金额:$20.76万
-
财政年份:1989
-
负责人:HERBERT H SAMUELS
-
依托单位:
PHOTOAFFINITY LABELING OF THYROID HORMONE RECEPTORS
-
批准号:3152499
-
项目类别:
-
资助金额:$9.89万
-
财政年份:1983
-
负责人:HERBERT H SAMUELS
-
依托单位:
MULTIHORMONAL REGULATION OF GROWTH HORMONE SYNTHESIS
-
批准号:3151385
-
项目类别:
-
资助金额:$14.13万
-
财政年份:1978
-
负责人:HERBERT H SAMUELS
-
依托单位:
METABOLIC EFFECTS OF THYROID HORMONE
-
批准号:2137017
-
项目类别:
-
资助金额:$62.86万
-
财政年份:1976
-
负责人:HERBERT H SAMUELS
-
依托单位:
METABOLIC EFFECTS OF THYROID HORMONE
-
批准号:3483145
-
项目类别:
-
资助金额:$47.51万
-
财政年份:1976
-
负责人:HERBERT H SAMUELS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: